Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2009, Vol. 29 Issue (11): 123-128    DOI:
    
Trends and Strategies of Biomedical Industry Development
SU Yue1,LIU Nan2
1.China Nation Centre for Biotechnology Development, Beijing 100036, China
2.Tianjin Key Laboratory of Risk Assessment and Control Technology for Environment and Food Safety, Institute of Hygiene and Environment Medicine, Academy of Military Medical Science, Tianjin 300050, China
Download: HTML   PDF(507KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Nowadays, biomedical industry has been cultivated as a new source of economic growth in many countries, and its development has been accelerated through adopting different policies and measurements by those governments. Encouraged by policies of advantages and the financial support of the government, Chinese biomedical industry is hopeful to bounce back from the economic crisis soon and embrace the period of rapid growth. By the guidance of our government, a strategic alliance of technology innovation of the bio-industry has been establishing, its resources conformity and advantages mutual complementarities have been promoting, and a mass of stronger innovative enterprises have been forming and clustering by vigorous construction of several hi-tech industry parks. They spur the development and technical innovation of national biomedical industry. The development trends and key points should be broken through cooperation among industries, universities and researches; advanced biotechnology; market access policies and high-standard elites construction, etc. By the guidance of market, the government should put forth a series of plans and policies for industry development to accelerate the construction of industrialized bases of biomedical industry, and encourage the biotech enterprises to finance in multi-channels and forms. Some measurements should be taken to deal with the rapid development of biomedical industry in our country, such as establishing the sharing mechanism of biomedical industry resources and public communication platform, the leading enterprises should play the main role and support the merger and acquisition among big enterprises, strengthening the construction of relative rules and regulations and integrating laws of bio-safe and relative intellectual property rights, etc.



Received: 22 September 2009      Published: 07 December 2009
ZTFLH:  Q789  
Cite this article:

SU Ru, LIU Nan. Trends and Strategies of Biomedical Industry Development. China Biotechnology, 2009, 29(11): 123-128.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2009/V29/I11/123

[1]   科学技术部社会发展科技司. 生物医药发展战略报告—产业篇. 北京:科学出版社,2009 Social Development Department, Ministry of Science and Technology.Strategy Report of Biomedicine DevelopmentIndustry. Beijing: Science Press, 2009
[2]   刘燕华,王宏广. 发展医药科技 建造医药强国——中国医药科技与产业竞争力国际比较. 北京:中国医药科技出版社,2007. 38~40 Liu Y H, Wang H G.Developing Science and Technology of Medicine Constitute the Medical Strong ContryScience and Technology of Medicine in China and the International Comparison of Industry Competition. Beijing:Chinese Medical Science and Technology Press, 2007. 38~40
[3]   李学勇,王宏广. 发展生物技术,引领生物经济. 北京:中国医药科技出版社,2005.14,15 Li X Y, Wang H G.Developing Biotechnology,Leading Bioeconomy.Beijing: Chinese Medical Science and Technology Press, 2005.14~15
[4]   2007中国生物技术发展报告. 北京:中国农业出版社,2008 Report of Biotechnology Development in China 2007. Beijing: Chinese Agriculture Press, 2008
[5]   吴光庆. 抗体专利技术的现状与发展趋势.中国知识产权研究会:各行业专利技术现状及发展趋势报告2007~2008. 北京:科学出版社,2008.150~172 Wu G Q.Status in quo and developing trends of antibody patent technology. Chinese Seminar for Intellectual Property Rights: Reports of Status in quo and Developing Trends of Patent Technology in all Industries 2007~2008. Beijing: Science Press, 2008.150~172
[6]   Kalorama Information. The protein therapeutics market: The science and business of a growing sector. 2006
[1] XIA Wen-yue, WANG Jing, ZHAO Bing-xin, PAN Xiao-xia, WEN Yu-ling, CHEN Yuan-ding . Comparative Analysis of Two Rotavirus VP4 Epitopes Inserted on the Same Site of VP6 Vector Protein[J]. China Biotechnology, 2015, 35(8): 9-15.
[2] GAO Fei, ZHOU Jing, LIU Xiao-tong, LI Cheng-lei, YAO Hui-peng, ZHAO Hai-xia, WU Qi . Cloning and Expression Analysis One Zinc Finger Protein Gene FtLOL1 in Fagopyrum tataricum: Effect of Abiotic Stress[J]. China Biotechnology, 2015, 35(8): 44-50.
[3] WANG Qing, XU Yan-zhao, WEI Xiao-xiao, WANG Qiu-xia, HANG Bo-lin, SUN Ya-wei, WANG Fei-fei, HU Jian-he . Preparation of Polyclonal Antiserums of GP5a Protein of Porcine Reproductive and Respiratory Syndrome Virus[J]. China Biotechnology, 2015, 35(8): 38-43.
[4] WAN Fang, ZHANG Bin, CHEN Min-liang, CHEN Jin-cong, CHEN Xue-lan . Effects of proC and putP Deletion on Physiological Metabolism of L-arginine-producing Strain Corynebacterium crenatum[J]. China Biotechnology, 2015, 35(8): 51-58.
[5] CHANG Yu-mei, HOU Zhan-ming . Research on Gene Knockout and Function of FgPDE1 in Fusarium graminearum[J]. China Biotechnology, 2015, 35(8): 59-67.
[6] SHEN Dong-ling, SHANG Shu-mei, LI Wei-na, YAN Jin-ping, HANGAN Ir-bis. Characterization of the Disrupted ack Genes on Fermentation by Thermoanaerobacterium calidifontis Rx1[J]. China Biotechnology, 2015, 35(7): 37-44.
[7] LUO Wan-yue, LI Tian-ming, YU Ying, XU Mei-xue, YI Hong. Construction of an Inducible Expression Shuttle Vector for Ketogulonigenium vulgare Allowing Tightly Regulable Gene Expression[J]. China Biotechnology, 2015, 35(5): 81-86.
[8] XIAO Shi-yuan, XU Jing-liang, CHEN Xiao-yan, YANG liu, YUAN Zhen-hong. Production of the Isoamyl Alcohol in E.coli by Expression of kivD Gene[J]. China Biotechnology, 2015, 35(4): 60-65.
[9] GONG Long-cai, LUO Zhen-ming, YANG Yan-qing, WANG Zhen-yu, XIANG Jun-jian, WANG Hong. Prokaryotic Expression and Identification of cTnI-linker-TnC Fusion Protein[J]. China Biotechnology, 2015, 35(4): 48-53.
[10] CHEN Jing-jing, XING Gui-chun, ZHANG Ling-qiang. Generation of FBXL15 Conditional Knockout Mice Using the Loxp-Cre Strategy[J]. China Biotechnology, 2015, 35(4): 74-79.
[11] FANG Shi-xiong, MA Yi, SHEN Shu-tao, ZHAO Shao-jun, HONG An. Efficient Preparation of TNFα Derivatives TRSP10 and Preliminary Study of Its Inhibitory Effect on Prostate Cancer DU145 Cells[J]. China Biotechnology, 2015, 35(4): 11-16.
[12] WANG Xiao-yan, CHEN Na-zi, AI Jun, ZHAO Yang, WU Mei-yu, HUANG Jin-zhi, JIANG Chao, LI Xiao-kun. Expression and Purification of Biological-active Recombinant HBV Precore Protein-Mouse IgG Fc Based on Baculovirus Expression Vector System[J]. China Biotechnology, 2015, 35(4): 42-47.
[13] LI Ming, WANG Yong-fei, JIAO Jin-xia, YANG Yang, ZHANG Ning, XING Xiang-bin, MA San-mei. The Expression of OPCML in Gastric Cancer and Role of OPCML in Biological Function of Gastric Cancer Cell[J]. China Biotechnology, 2015, 35(2): 1-7.
[14] LIU Ya-long, YAN Dong-ming, WENG Liang, ZOU Xue, LIU Dan, PENG Chao, SU Ya-nan, YAN Jin-jin, ZHANG Jing, GUO Zhi-yan. Pilot-scale Fermentation and Purification of a Recombinant E. coli Heat-labile Enterotoxin B Subunit[J]. China Biotechnology, 2015, 35(2): 78-83.
[15] LIU Yang, YANG Ya-lin, ZHANG Yu-ting, RAN Chao, ZHOU Zhi-gang. Expression, Purification and Characterization of β-N-acetylglucosaminidase from Aeromonas veronii B565[J]. China Biotechnology, 2015, 35(2): 38-44.